Biocon plan to open a training campus for graduates
Biocon the Biopharma major is planning to set up an academic institution called Biocon Academy next financial year.
Biocon the Biopharma major is planning to set up an academic institution called Biocon Academy next financial year.
As the Vice President and General Manager of Quest Diagnostics, Dr Sumit Dutta is responsible for creating an environment of quality, integrity and success for patients, customers and employees. Today, Quest Diagnostics is one of the largest pathology laboratories in the world.
Dr Krishnaswamy Kasturirangan, Member, Planning Commission, has steered the Indian Space programme for over nine years as Chairman of the Indian Space Research Organisation (ISRO), Space Commission and as Secretary to the Government of India.
Biotechnology company Biogen Idec has announced the introduction of TYSABRI (natalizumab) the first humanized, monoclonal antibody for the treatment of relapsing remitting MS in India.
Researchers have developed a new biochip technology, which could soon put a stop to the use of animals for testing in the chemical and cosmetics industries.
India and France will collaborate to explore the possibilities of RNAi (RNA interference) in areas of basic medical research and biotechnology.
First health institute in Nagaland inauguratedThe first health institute to be set up in the North-eastern state of India, Christian […]
Novotech, the largest independent clinical research organisation in Australia, has selected Oracle
Biocon, India’s largest biotechnology company, entered into an agreement with Teleradiology Solutions, a pioneer of the domain in India, to provide teleradiology reporting services to Clinigene, Biocon’s Clinical Research Organisation.
With the world’s attention continuously focused on the Indian healthcare sector, and this market more dynamic than ever, it is essential for the industry to have an annual platform to recognise the exemplary work done by organisations and individuals for their significant contributions and achievements.
As part of the Cegedim Dendrite Alliance Program, created to expand its open business model through alliances with leading technology, software and consulting companies, Cegedim Dendrite, world
The International BIO 2010 convention, held recently in Chicago, was a chance to promote French expertise and strengths in the biotechnologies sector. Almost half of all new drugs on the world market have their origins in biotechnologies.
India has the potential to significantly improve healthcare in the next 25 to 30 years provided it steps up capacity for generating and translating scientific and technological advancements into medical innovations.